April 22, 2026
10x Science: The founders who built the field are now building the platform
The tools used to characterize protein-based drugs haven’t fundamentally changed in over twenty years. As AI floods the discovery pipeline with more candidates than ever, that bottleneck is now one of the most expensive unsolved problems in drug development. 10x Science is fixing it, and we led their $4.8M seed.
Keep reading
Founder spotlight
Life at a Startup
"”If we do our jobs well, we’ll fundamentally change how software gets built and help make developers more productive.” "
Welcome to "Life at a Startup: Inside Look." This series reveals the day-to-day realities, challenges, and wins of startup life within the Initialized portfolio. Go inside Greptile's SF office with us.
